EPO Patent EP3722318A1: Multispecific Antigen-Binding Molecules

ChangeBridge: EPO Bulletin - Peptides (C07K)

Published March 11th, 2026

Detected March 26th, 2026

Summary

The European Patent Office has published patent application EP3722318A1 concerning multispecific antigen-binding molecules, filed by Regeneron Pharmaceuticals, Inc. The publication date is March 11, 2026, and it covers various classifications related to antibodies and their uses.

View original document View source feed page

What changed

This document is a publication of a European patent application (EP3722318A1) by Regeneron Pharmaceuticals, Inc., detailing "Multispecific Antigen-Binding Molecules and Uses Thereof." The publication date is March 11, 2026, and it includes International Patent Classification codes related to antibodies and pharmaceutical compositions.

This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations on regulated entities. Legal and R&D departments may wish to review for competitive intelligence or potential licensing opportunities. No immediate action is required from a compliance perspective.

Source document (simplified)

← EPO Patent Bulletin

MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF

Publication EP3722318A1 Kind: A1 Mar 11, 2026

Applicants

Regeneron Pharmaceuticals, Inc.

Inventors

ANDREEV, Julian, THAMBI, Nithya, DELFINO, Frank, MARTIN, Joel, THURSTON, Gavin, CYGNAR, Katherine, PAPADOPOULOS, Nicholas

IPC Classifications

C07K 16/28 20060101AFI20200804BHEP C07K 16/46 20060101ALI20200804BHEP C07K 16/22 20060101ALI20200804BHEP C07K 16/12 20060101ALI20200804BHEP C07K 16/32 20060101ALI20200804BHEP C07K 16/18 20060101ALI20200804BHEP C07K 14/435 20060101ALI20200804BHEP A61K 47/68 20170101ALI20200804BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →